These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 10215340

  • 1. The ET(A) receptor blocker LU 135252 prevents chronic transplant nephropathy in the "Fisher to Lewis" model.
    Orth SR, Odoni G, Amann K, Strzelczyk P, Raschack M, Ritz E.
    J Am Soc Nephrol; 1999 Feb; 10(2):387-91. PubMed ID: 10215340
    [Abstract] [Full Text] [Related]

  • 2. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant nephropathy in a 'Fisher-to-Lewis' rat model.
    Adams J, Odoni G, Ogata H, Viedt C, Amann K, Ritz E, Orth SR.
    Nephrol Dial Transplant; 2002 May; 17(5):780-7. PubMed ID: 11981063
    [Abstract] [Full Text] [Related]

  • 3. Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats.
    Orth SR, Esslinger JP, Amann K, Schwarz U, Raschack M, Ritz E.
    Hypertension; 1998 Apr; 31(4):995-1001. PubMed ID: 9535426
    [Abstract] [Full Text] [Related]

  • 4. Combination treatment with an ET(A)-receptor blocker and an ACE inhibitor is not superior to the respective monotherapies in attenuating chronic transplant vasculopathy in different aorta allotransplantation rat models.
    Orth SR, Odoni G, Karkoszka H, Ogata H, Viedt C, Amann K, Ferrari P, Ritz E.
    Nephrol Dial Transplant; 2003 Jan; 18(1):62-9. PubMed ID: 12480961
    [Abstract] [Full Text] [Related]

  • 5. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.
    Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Yard B, Kirchengast M, Tullius SG, Schnülle P, van der Woude FJ, Rohmeiss P.
    Transplantation; 1999 Sep 27; 68(6):739-46. PubMed ID: 10515373
    [Abstract] [Full Text] [Related]

  • 6. Treatment with a combined endothelin A/B-receptor antagonist does not prevent chronic renal allograft rejection in rats.
    Braun C, Conzelmann T, Vetter S, Schaub M, Back WE, Kirchengast M, Tullius SG, Schnülle P, van der Woude FJ, Rohmeiss P.
    J Cardiovasc Pharmacol; 2000 Oct 27; 36(4):428-37. PubMed ID: 11026642
    [Abstract] [Full Text] [Related]

  • 7. Influence of acute selective endothelin-receptor-A blockade on renal hemodynamics in a rat model of chronic allograft rejection.
    Knoll T, Oltersdorf J, Göttmann U, Schaub M, Michel MS, Kirchengast M, van der Woude FJ, Rohmeiss P, Braun C.
    Transpl Int; 2003 Jun 27; 16(6):425-9. PubMed ID: 12819874
    [Abstract] [Full Text] [Related]

  • 8. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
    Brochu E, Lacasse S, Moreau C, Lebel M, Kingma I, Grose JH, Larivière R.
    Nephrol Dial Transplant; 1999 Aug 27; 14(8):1881-8. PubMed ID: 10462266
    [Abstract] [Full Text] [Related]

  • 9. ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.
    Hocher B, Kalk P, Slowinski T, Godes M, Mach A, Herzfeld S, Wiesner D, Arck PC, Neumayer HH, Nafz B.
    J Am Soc Nephrol; 2003 Feb 27; 14(2):367-76. PubMed ID: 12538737
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure.
    Brochu E, Lacasse S, Larivière R, Kingma I, Grose JH, Lebel M.
    J Am Soc Nephrol; 1999 Jul 27; 10(7):1440-6. PubMed ID: 10405199
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Candesartan cilexetil reduces chronic renal allograft injury in Fisher-->Lewis rats.
    Mackenzie HS, Ziai F, Nagano H, Azuma H, Troy JL, Rennke HG, Tilney NL, Brenner BM.
    J Hypertens Suppl; 1997 Dec 27; 15(6):S21-5. PubMed ID: 9493123
    [Abstract] [Full Text] [Related]

  • 18. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML, El-Shakmak A, Szábó A, Koch A, Kuhlmann A, Münter K, Ritz E, Amann K.
    Diabetologia; 2003 Jun 27; 46(6):856-68. PubMed ID: 12802493
    [Abstract] [Full Text] [Related]

  • 19. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy.
    Benigni A, Corna D, Maffi R, Benedetti G, Zoja C, Remuzzi G.
    Kidney Int; 1998 Aug 27; 54(2):353-9. PubMed ID: 9690201
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.